Q2 2022 Holdings
Filed 2022-08-15 | 10 holdings | $820.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics, Inc. | COM | 48576A100 | $368.5K | 2,912,872 | 44.9% |
| Eqrx, Inc. | COM | 26886C107 | $170.4K | 36,335,375 | 20.8% |
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $152.1K | 5,168,749 | 18.5% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $61.6K | 11,055,554 | 7.5% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $38.3K | 2,508,809 | 4.7% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $14.5K | 3,798,926 | 1.8% |
| Revolution Healthcare Acquisition Corp. | COM | 76155Y108 | $13.3K | 1,357,237 | 1.6% |
| Metacrine, Inc. | COM | 59101E103 | $1.5K | 2,940,503 | 0.2% |
| Rubius Therapeutics, Inc. | COM | 78116T103 | $298 | 349,908 | 0.0% |
| Zymergen Inc. | COM | 98985X100 | $147 | 119,205 | 0.0% |